Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PACB · against 588 other Healthcare companies listed in US-listed
Ranked #73 of 589 · scores higher than 87% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 70–79, including PACB · Click a bar to see the companies
Mainly thanks to its EBITDA yield, which is stronger than most Healthcare peers.
| Metric | PACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -17.6% | -4.3% | 24% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 16.2% | -0.8% | 94% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | -17.2% | -2.3% | 20% | 20% | |
| Book yieldHigher is better · 587 reported | -4.4% | 25.9% | 7% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 62 | 314M USD | 75 | 56 | |
| 71 | 63.0B USD | 74 | 65 | |
| 71 | 36.4B USD | 74 | 50 | |
| 73 | 13.3B USD | 73 | 59 | |
| 73 | 758M USD | 73 | 35 | |
| 73 | 18.5B USD | 73 | 54 | |
| 76 | 10.8B USD | 72 | 54 | |
| 76 | 14.9B USD | 72 | 65 | |
| 76 | 561M USD | 72 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score